The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Evolutionary Determinants of Cancer
Open accessAbstract
Our understanding of cancer is being transformed by exploring clonal diversity, drug resistance, and causation within an evolutionary framework. The therapeutic resilience of advanced cancer is a consequence of its character as a complex, dynamic, and adaptive ecosystem engendering robustness, underpinned by genetic diversity and epigenetic plasticity. The risk of mutation-driven escape by self-renewing cells is intrinsic to multicellularity but is countered by multiple restraints, facilitating increasing complexity and longevity of species. But our own species has disrupted this historical narrative by rapidly escalating intrinsic risk. Evolutionary principles illuminate these challenges and provide new avenues to explore for more effective control. Significance: Lifetime risk of cancer now approximates to 50% in Western societies. And, despite many advances, the outcome for patients with disseminated disease remains poor, with drug resistance the norm. An evolutionary perspective may provide a clearer understanding of how cancer clones develop robustness and why, for us as a species, risk is now off the scale. And, perhaps, of what we might best do to achieve more effective control. Cancer Discov; 5(8); 806–20. ©2015 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · cited 1×
“And, as with evolutionary innovations in general, mutations in cancer arise by a stochastic process that may leave mechanistic footprints (77) but is entirely independent of, or blind to, functional consequences or utility (78).”
BackgroundSelf-citationNowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · cited 1×
“Normal stem cells are prime targets for the initiation of malignant transformation (115), but downstream progenitors, prior to terminal differentiation, can acquire self-renewal capacity by mutational changes (116) or microenvironmental pressures, as in zones of hypoxia (117) or with metastatic spread and epithelial–m…”
BackgroundGreaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Self-citationClinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
A Map of Recent Positive Selection in the Human Genome
Voight, B. F., Kudaravalli, S., Wen, X., & Pritchard, J. K. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040072 · Cited by 2,893
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Punctuated equilibria: the tempo and mode of evolution reconsidered
Gould, S. J., & Eldredge, N. (1977) · Paleobiology · doi:10.1017/s0094837300005224 · Cited by 2,659
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414 · cited 1×
“There is increasing evidence for the latter in cancer (33), propelled by the onset of genetic instability (34), chromothripsis (35), or highimpact single mutations (36, 37).”
BackgroundKitano, H. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1471 · Cited by 2,278
The causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
Evolution of the Cancer Stem Cell Model
Kreso, A., & Dick, J. E. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,224
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162 · cited 1×
“Complex genetic and signaling networks were a very early evolutionary innovation in bacteria (88) and are very evident in yeast (89).”
BackgroundPersister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 1×
“Bacteria, as well as normal stem cells, adopt a dormant state—or “hunker down”—when under stress (83).”
BackgroundClonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
Lewontin, R. C. (1970) · Annual Review of Ecology and Systematics · doi:10.1146/annurev.es.01.110170.000245 · Cited by 1,924
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Efficient tumour formation by single human melanoma cells
Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796
Kirkwood, T. B. L., & Austad, S. N. (2000) · Nature · doi:10.1038/35041682 · Cited by 1,774
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
High burden and pervasive positive selection of somatic mutations in normal human skin
Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D. C., Fullam, A., Alexandrov, L. B., Tubio, J. M., et al. (2015) · Science · doi:10.1126/science.aaa6806 · Cited by 1,770
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Cancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699
Models, mechanisms and clinical evidence for cancer dormancy
Aguirre-Ghiso, J. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2256 · Cited by 1,677
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells
Ramsköld, D., Luo, S., Wang, Y.-C., Li, R., Deng, Q., Faridani, O. R., Daniels, G. A., Khrebtukova, I., Loring, J. F., Laurent, L. C., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2282 · Cited by 1,609
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497 · cited 1×
“Some of the tactics available may not bring about elimination of all cancer cells but rather slow down the evolutionary process, as with aspirin in gastrointestinal tumors (186, 187), or redirect and sustain stem cell dormancy, as with ABL kinase inhibitors in chronic myeloid leukemia (188).”
BackgroundStochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., & Lander, E. S. (2011) · Cell · doi:10.1016/j.cell.2011.07.026 · Cited by 1,475
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Visvader, J. E. (2011) · Nature · doi:10.1038/nature09781 · Cited by 1,449
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins
Weinreich, D. M., Delaney, N. F., DePristo, M. A., & Hartl, D. L. (2006) · Science · doi:10.1126/science.1123539 · Cited by 1,415
An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control
Clevers, H., Loh, K. M., & Nusse, R. (2014) · Science · doi:10.1126/science.1248012 · Cited by 1,364
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339
Punctuated Evolution of Prostate Cancer Genomes
Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T. Y., Ghandi, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.021 · Cited by 1,320
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317 · cited 3×
“To some extent, this is rescued by multiregional sampling coupled with the application of molecular clocks and spatio-temporal modeling (10), by serial sampling from different stages of disease (22, 23), or by “real-time” screening of tumor-derived DNA fragments in plasma (24–26).”
BackgroundLowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
Phylogenomics and the reconstruction of the tree of life
Delsuc, F., Brinkmann, H., & Philippe, H. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1603 · Cited by 1,236
Gerlinger, M., Horswell, S., Larkin, J., Rowan, A. J., Salm, M. P., Varela, I., Fisher, R., McGranahan, N., Matthews, N., Santos, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2891 · Cited by 1,208
Evolutionary Dynamics of Biological Games
Nowak, M. A., & Sigmund, K. (2004) · Science · doi:10.1126/science.1093411 · Cited by 1,184
Graham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,181
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Shackleton, M., Quintana, E., Fearon, E. R., & Morrison, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.08.017 · Cited by 1,162
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Wilson, T. R., Fridlyand, J., Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., et al. (2012) · Nature · doi:10.1038/nature11249 · Cited by 1,134 · cited 1×
“Signal block bypass, for some targeted therapies (85, 86), is a consequence of highly networked signaling for cellular metabolism and cycling with built-in redundancy as a failsafe.”
BackgroundDnmt3a is essential for hematopoietic stem cell differentiation
Challen, G. A., Sun, D., Jeong, M., Luo, M., Jelinek, J., Berg, J. S., Bock, C., Vasanthakumar, A., Gu, H., Xi, Y., et al. (2012) · Nature Genetics · doi:10.1038/ng.1009 · Cited by 1,122
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
de Bruin, E. C., McGranahan, N., Mitter, R., Salm, M., Wedge, D. C., Yates, L., Jamal-Hanjani, M., Shafi, S., Murugaesu, N., Rowan, A. J., et al. (2014) · Science · doi:10.1126/science.1253462 · Cited by 1,117
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Magee, J. A., Piskounova, E., & Morrison, S. J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.003 · Cited by 1,101
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution
McGranahan, N., & Swanton, C. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.001 · Cited by 1,077
Combinatorial drug therapy for cancer in the post-genomic era
Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070 · cited 1×
“It is well recognized that drug combinations will be required to thwart resistance (181), but the design of therapeutic strategies should be informed by a sounder grasp of the underlying biology (110) and explored by appropriate in vitro and in vivo modeling.”
BackgroundPreexistence and clonal selection of MET amplification in EGFR mutant NSCLC
Turke, A. B., Zejnullahu, K., Wu, Y.-L., Song, Y., Dias-Santagata, D., Lifshits, E., Toschi, L., Rogers, A., Mok, T., Sequist, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.022 · Cited by 1,059
Stem cell gene expression programs influence clinical outcome in human leukemia
Eppert, K., Takenaka, K., Lechman, E. R., Waldron, L., Nilsson, B., van Galen, P., Metzeler, K. H., Poeppl, A., Ling, V., Beyene, J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2415 · Cited by 1,041
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Wang, Y., Waters, J., Leung, M. L., Unruh, A., Roh, W., Shi, X., Chen, K., Scheet, P., Vattathil, S., Liang, H., et al. (2014) · Nature · doi:10.1038/nature13600 · Cited by 1,029
A Big Bang model of human colorectal tumor growth
Sottoriva, A., Kang, H., Ma, Z., Graham, T. A., Salomon, M. P., Zhao, J., Marjoram, P., Siegmund, K., Press, M. F., Shibata, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3214 · Cited by 1,015
CONVERGENCE, ADAPTATION, AND CONSTRAINT
Losos, J. B. (2011) · Evolution · doi:10.1111/j.1558-5646.2011.01289.x · Cited by 985
Monod, J. (1974) · Studies in the Philosophy of Biology · doi:10.1007/978-1-349-01892-5_20 · Cited by 967
DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Bernard, L., Viale, G., Pelicci, P. G., & Di Fiore, P. P. (2010) · Cell · doi:10.1016/j.cell.2009.12.007 · Cited by 947
Merlos-Suárez, A., Barriga, F. M., Jung, P., Iglesias, M., Céspedes, M. V., Rossell, D., Sevillano, M., Hernando-Momblona, X., da Silva-Diz, V., Muñoz, P., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.02.020 · Cited by 934
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Wong, T. N., Ramsingh, G., Young, A. L., Miller, C. A., Touma, W., Welch, J. S., Lamprecht, T. L., Shen, D., Hundal, J., Fulton, R. S., et al. (2015) · Nature · doi:10.1038/nature13968 · Cited by 892
Gatenby, R. A., Silva, A. S., Gillies, R. J., & Frieden, B. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3658 · Cited by 846
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822 · cited 1×
“Drug efflux pumps are very active in most normal and cancer stem cells, not to frustrate therapy (which they do) but as a long-standing adaptation to protect the limited pool of essential normal stem cells, and other critical tissue sites (the placenta and blood–brain barrier), from xenotoxic damage (140).”
Clonal dynamics of native haematopoiesis
Sun, J., Ramos, A., Chapman, B., Johnnidis, J. B., Le, L., Ho, Y.-J., Klein, A., Hofmann, O., & Camargo, F. D. (2014) · Nature · doi:10.1038/nature13824 · Cited by 821
Carlson, J. M., & Doyle, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012582499 · Cited by 814
Genetic variegation of clonal architecture and propagating cells in leukaemia
Anderson, K., Lutz, C., van Delft, F. W., Bateman, C. M., Guo, Y., Colman, S. M., Kempski, H., Moorman, A. V., Titley, I., Swansbury, J., et al. (2011) · Nature · doi:10.1038/nature09650 · Cited by 806
Self-citationTumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment
Anderson, A. R. A., Weaver, A. M., Cummings, P. T., & Quaranta, V. (2006) · Cell · doi:10.1016/j.cell.2006.09.042 · Cited by 754
Genetic instability and darwinian selection in tumours
Cahill, D. P., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01661-x · Cited by 748
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Kreso, A., O'Brien, C. A., van Galen, P., Gan, O. I., Notta, F., Brown, A. M. K., Ng, K., Ma, J., Wienholds, E., Dunant, C., et al. (2013) · Science · doi:10.1126/science.1227670 · Cited by 744
Guevara-Aguirre, J., Balasubramanian, P., Guevara-Aguirre, M., Wei, M., Madia, F., Cheng, C.-W., Hwang, D., Martin-Montalvo, A., Saavedra, J., Ingles, S., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001845 · Cited by 743
Human skin pigmentation as an adaptation to UV radiation
Jablonski, N. G., & Chaplin, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914628107 · Cited by 728 · cited 1×
“The selective pressure was solar UVB damage to the skin with consequent skin cancer (152), folate loss (153), or other lethal pathologies.”
BackgroundA microenvironmental model of carcinogenesis
Gatenby, R. A., & Gillies, R. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2255 · Cited by 721
Defining the mode of tumour growth by clonal analysis
Driessens, G., Beck, B., Caauwe, A., Simons, B. D., & Blanpain, C. (2012) · Nature · doi:10.1038/nature11344 · Cited by 717
Empirical fitness landscapes and the predictability of evolution
de Visser, J. A. G. M., & Krug, J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3744 · Cited by 715
The Increasing Complexity of the Cancer Stem Cell Paradigm
Rosen, J. M., & Jordan, C. T. (2009) · Science · doi:10.1126/science.1171837 · Cited by 698
Genetic clonal diversity predicts progression to esophageal adenocarcinoma
Maley, C. C., Galipeau, P. C., Finley, J. C., Wongsurawat, V. J., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., Risques, R.-A., Rabinovitch, P. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1768 · Cited by 696
The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., Minucci, S., Di Fiore, P. P., & Pelicci, P. G. (2009) · Cell · doi:10.1016/j.cell.2009.06.048 · Cited by 696
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
McGranahan, N., Favero, F., de Bruin, E. C., Birkbak, N. J., Szallasi, Z., & Swanton, C. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1408 · Cited by 685
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
Gillies, R. J., Verduzco, D., & Gatenby, R. A. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3298 · Cited by 684
Longevity Among Hunter‐ Gatherers: A Cross‐Cultural Examination
Gurven, M., & Kaplan, H. (2007) · Population and Development Review · doi:10.1111/j.1728-4457.2007.00171.x · Cited by 670
Infection, immune responses and the aetiology of childhood leukaemia
Greaves, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1816 · Cited by 640
Self-citationEvolution of the cancer genome
Yates, L. R., & Campbell, P. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3317 · Cited by 640
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Eirew, P., Steif, A., Khattra, J., Ha, G., Yap, D., Farahani, H., Gelmon, K., Chia, S., Mar, C., Wan, A., et al. (2015) · Nature · doi:10.1038/nature13952 · Cited by 598
Stress-Induced Mutagenesis in Bacteria
Bjedov, I., Tenaillon, O., Gérard, B., Souza, V., Denamur, E., Radman, M., Taddei, F., & Matic, I. (2003) · Science · doi:10.1126/science.1082240 · Cited by 587
Effect of Mutation Order on Myeloproliferative Neoplasms
Ortmann, C. A., Kent, D. G., Nangalia, J., Silber, Y., Wedge, D. C., Grinfeld, J., Baxter, E. J., Massie, C. E., Papaemmanuil, E., Menon, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412098 · Cited by 562
Cell-of-origin chromatin organization shapes the mutational landscape of cancer
Polak, P., Karlić, R., Koren, A., Thurman, R., Sandstrom, R., Lawrence, M. S., Reynolds, A., Rynes, E., Vlahoviček, K., Stamatoyannopoulos, J. A., et al. (2015) · Nature · doi:10.1038/nature14221 · Cited by 557 · cited 1×
“The emergence of mutational complexity, clonal trajectories, or architectures and clinical subtypes is therefore constrained by the cell type of origin (54) and by the early or initiating mutations that reset genotypic signaling networks and cellular phenotypes (10, 55).”
BackgroundLeukemia in twins: lessons in natural history
Greaves, M. F., Maia, A. T., Wiemels, J. L., & Ford, A. M. (2003) · Blood · doi:10.1182/blood-2002-12-3817 · Cited by 543
Self-citationInda, M.-D.-M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D. W. Y., Vandenberg, S., Brennan, C., Johns, T. G., Bachoo, R., Hadwiger, P., et al. (2010) · Genes & Development · doi:10.1101/gad.1890510 · Cited by 543
Is Genetic Evolution Predictable?
Stern, D. L., & Orgogozo, V. (2009) · Science · doi:10.1126/science.1158997 · Cited by 535
Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
Vago, L., Perna, S. K., Zanussi, M., Mazzi, B., Barlassina, C., Stanghellini, M. T. L., Perrelli, N. F., Cosentino, C., Torri, F., Angius, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0811036 · Cited by 529
Self-renewal as a therapeutic target in human colorectal cancer
Kreso, A., van Galen, P., Pedley, N. M., Lima-Fernandes, E., Frelin, C., Davis, T., Cao, L., Baiazitov, R., Du, W., Sydorenko, N., et al. (2014) · Nature Medicine · doi:10.1038/nm.3418 · Cited by 500
Intratumor Heterogeneity: Seeing the Wood for the Trees
Yap, T. A., Gerlinger, M., Futreal, P. A., Pusztai, L., & Swanton, C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003854 · Cited by 490
Dynamics of cancer progression
Michor, F., Iwasa, Y., & Nowak, M. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1295 · Cited by 483
Cancer across the tree of life: cooperation and cheating in multicellularity
Aktipis, C. A., Boddy, A. M., Jansen, G., Hibner, U., Hochberg, M. E., Maley, C. C., & Wilkinson, G. S. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0219 · Cited by 466
Quantitative evolutionary dynamics using high-resolution lineage tracking
Levy, S. F., Blundell, J. R., Venkataram, S., Petrov, D. A., Fisher, D. S., & Sherlock, G. (2015) · Nature · doi:10.1038/nature14279 · Cited by 460
Suppression of cancer relapse and metastasis by inhibiting cancer stemness
Li, Y., Rogoff, H. A., Keates, S., Gao, Y., Murikipudi, S., Mikule, K., Leggett, D., Li, W., Pardee, A. B., & Li, C. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424171112 · Cited by 458
Cancer as a robust system: implications for anticancer therapy
Kitano, H. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1300 · Cited by 456
Integrative mathematical oncology
Anderson, A. R. A., & Quaranta, V. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2329 · Cited by 446
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
Lee, R. S., Stewart, C., Carter, S. L., Ambrogio, L., Cibulskis, K., Sougnez, C., Lawrence, M. S., Auclair, D., Mora, J., Golub, T. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64400 · Cited by 428
Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling
Yuan, Y., Failmezger, H., Rueda, O. M., Ali, H. R., Gräf, S., Chin, S.-F., Schwarz, R. F., Curtis, C., Dunning, M. J., Bardwell, H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004330 · Cited by 426
Genetic Interactions in Cancer Progression and Treatment
Ashworth, A., Lord, C. J., & Reis-Filho, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.03.020 · Cited by 426
Defining Stem Cell Dynamics in Models of Intestinal Tumor Initiation
Vermeulen, L., Morrissey, E., van der Heijden, M., Nicholson, A. M., Sottoriva, A., Buczacki, S., Kemp, R., Tavaré, S., & Winton, D. J. (2013) · Science · doi:10.1126/science.1243148 · Cited by 397
Initiating and Cancer-Propagating Cells in TEL-AML1 -Associated Childhood Leukemia
Hong, D., Gupta, R., Ancliff, P., Atzberger, A., Brown, J., Soneji, S., Green, J., Colman, S., Piacibello, W., Buckle, V., et al. (2008) · Science · doi:10.1126/science.1150648 · Cited by 397
Self-citationPeto's Paradox: evolution's prescription for cancer prevention
Caulin, A. F., & Maley, C. C. (2011) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2011.01.002 · Cited by 384
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Meyer, M., Reimand, J., Lan, X., Head, R., Zhu, X., Kushida, M., Bayani, J., Pressey, J. C., Lionel, A. C., Clarke, I. D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320611111 · Cited by 382
Insights into the evolution of longevity from the bowhead whale genome
Keane, M., Semeiks, J., Webb, A. E., Li, Y. I., Quesada, V., Craig, T., Madsen, L. B., van Dam, S., Brawand, D., Marques, P. I., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.008 · Cited by 375
van Rhenen, A., Feller, N., Kelder, A., Westra, A. H., Rombouts, E., Zweegman, S., van der Pol, M. A., Waisfisz, Q., Ossenkoppele, G. J., & Schuurhuis, G. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0468 · Cited by 375
for the Biallelic Mismatch Repair Deficiency Consortium, Shlien, A., Campbell, B. B., de Borja, R., Alexandrov, L. B., Merico, D., Wedge, D., Van Loo, P., Tarpey, P. S., Coupland, P., et al. (2015) · Nature Genetics · doi:10.1038/ng.3202 · Cited by 374
Epistasis as the primary factor in molecular evolution
Breen, M. S., Kemena, C., Vlasov, P. K., Notredame, C., & Kondrashov, F. A. (2012) · Nature · doi:10.1038/nature11510 · Cited by 363
The Implications of Clonal Genome Evolution for Cancer Medicine
Aparicio, S., & Caldas, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1204892 · Cited by 356
Tumor clone dynamics in lethal prostate cancer
Carreira, S., Romanel, A., Goodall, J., Grist, E., Ferraldeschi, R., Miranda, S., Prandi, D., Lorente, D., Frenel, J.-S., Pezaro, C., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009448 · Cited by 340
Park, S. Y., Gönen, M., Kim, H. J., Michor, F., & Polyak, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40724 · Cited by 324
Domazet-Lošo, T., & Tautz, D. (2010) · BMC Biology · doi:10.1186/1741-7007-8-66 · Cited by 311
Foulds, L. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90039-0 · Cited by 294
Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance
Palmer, A. C., & Kishony, R. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3351 · Cited by 285
Turning ecology and evolution against cancer
Korolev, K. S., Xavier, J. B., & Gore, J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3712 · Cited by 277
Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal
Sotillo, R., Schvartzman, J.-M., Socci, N. D., & Benezra, R. (2010) · Nature · doi:10.1038/nature08803 · Cited by 273
Selection and adaptation during metastatic cancer progression
Klein, C. A. (2013) · Nature · doi:10.1038/nature12628 · Cited by 273
Gilbert, O. M., Foster, K. R., Mehdiabadi, N. J., Strassmann, J. E., & Queller, D. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702723104 · Cited by 273
Evolutionary biology of cancer
Crespi, B., & Summers, K. (2005) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2005.07.007 · Cited by 259
Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors
Davies, P. C. W., & Lineweaver, C. H. (2011) · Physical Biology · doi:10.1088/1478-3975/8/1/015001 · Cited by 256
Pfeifer, H., Wassmann, B., Pavlova, A., Wunderle, L., Oldenburg, J., Binckebanck, A., Lange, T., Hochhaus, A., Wystub, S., Brück, P., et al. (2007) · Blood · doi:10.1182/blood-2006-11-052373 · Cited by 249
Spatial constraints control cell proliferation in tissues
Streichan, S. J., Hoerner, C. R., Schneidt, T., Holzer, D., & Hufnagel, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323016111 · Cited by 248
Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?
Attard, G., Cooper, C. S., & de Bono, J. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.11.006 · Cited by 242
Women's Reproductive Cancers in Evolutionary Context
Eaton, S. B., Pike, M. C., Short, R. V., Lee, N. C., Trussell, J., Hatcher, R. A., Wood, J. W., Worthman, C. M., Konner, M. J., Hill, K. R., et al. (1994) · The Quarterly Review of Biology · doi:10.1086/418650 · Cited by 241
Wnt signaling in stem and cancer stem cells
Wend, P., Holland, J. D., Ziebold, U., & Birchmeier, W. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.09.004 · Cited by 237
Comparative genetics of longevity and cancer: insights from long-lived rodents
Gorbunova, V., Seluanov, A., Zhang, Z., Gladyshev, V. N., & Vijg, J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3728 · Cited by 236
Tumor-Initiating Cells Are Rare in Many Human Tumors
Ishizawa, K., Rasheed, Z. A., Karisch, R., Wang, Q., Kowalski, J., Susky, E., Pereira, K., Karamboulas, C., Moghal, N., Rajeshkumar, N. V., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.009 · Cited by 229
Wang, J., Lu, F., Ren, Q., Sun, H., Xu, Z., Lan, R., Liu, Y., Ward, D., Quan, J., Ye, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0896 · Cited by 228
Architecture of inherited susceptibility to common cancer
Fletcher, O., & Houlston, R. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2840 · Cited by 222
Mroz, E. A., Tward, A. D., Pickering, C. R., Myers, J. N., Ferris, R. L., & Rocco, J. W. (2013) · Cancer · doi:10.1002/cncr.28150 · Cited by 220
Mice Lacking a Myc Enhancer That Includes Human SNP rs6983267 Are Resistant to Intestinal Tumors
Sur, I. K., Hallikas, O., Vähärautio, A., Yan, J., Turunen, M., Enge, M., Taipale, M., Karhu, A., Aaltonen, L. A., & Taipale, J. (2012) · Science · doi:10.1126/science.1228606 · Cited by 214
Life cycles, fitness decoupling and the evolution of multicellularity
Hammerschmidt, K., Rose, C. J., Kerr, B., & Rainey, P. B. (2014) · Nature · doi:10.1038/nature13884 · Cited by 213
Stoecklein, N. H., Hosch, S. B., Bezler, M., Stern, F., Hartmann, C. H., Vay, C., Siegmund, A., Scheunemann, P., Schurr, P., Knoefel, W. T., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.005 · Cited by 209
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition
Duy, C., Hurtz, C., Shojaee, S., Cerchietti, L., Geng, H., Swaminathan, S., Klemm, L., Kweon, S.-M., Nahar, R., Braig, M., et al. (2011) · Nature · doi:10.1038/nature09883 · Cited by 204
Win, T., Miles, K. A., Janes, S. M., Ganeshan, B., Shastry, M., Endozo, R., Meagher, M., Shortman, R. I., Wan, S., Kayani, I., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1307 · Cited by 203
Design principles of adaptive immune systems
Boehm, T. L. J. (2011) · Nature reviews. Immunology · doi:10.1038/nri2944 · Cited by 194
Leroi, A. M., Koufopanou, V., & Burt, A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1016 · Cited by 193
Darwinian medicine: a case for cancer
Greaves, M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2071 · Cited by 180
Self-citationHerrera, M., Islam, A. B. M. M. K., Herrera, A., Martín, P., García, V., Silva, J., Garcia, J. M., Salas, C., Casal, I., de Herreros, A. G., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0694 · Cited by 177
Plasticity within stem cell hierarchies in mammalian epithelia
Tetteh, P. W., Farin, H. F., & Clevers, H. C. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.09.003 · Cited by 176
High-Definition Reconstruction of Clonal Composition in Cancer
Fischer, A., Vázquez-García, I., Illingworth, C. J. R., & Mustonen, V. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.055 · Cited by 169
Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV
Goldberg, D. E., Siliciano, R. F., & Jacobs, W. R. (2012) · Cell · doi:10.1016/j.cell.2012.02.021 · Cited by 168
Pienta, K. J., McGregor, N., Axelrod, R., & Axelrod, D. E. (2008) · Translational Oncology · doi:10.1593/tlo.08178 · Cited by 168
Exploiting Evolution To Treat Drug Resistance: Combination Therapy and the Double Bind
Basanta, D., Gatenby, R. A., & Anderson, A. R. A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200458e · Cited by 163
The hen as a model of ovarian cancer
Johnson, P. A., & Giles, J. R. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3535 · Cited by 160
Naturally occurring tumours in the basal metazoan Hydra
Domazet-Lošo, T., Klimovich, A., Anokhin, B., Anton-Erxleben, F., Hamm, M. J., Lange, C., & Bosch, T. C. G. (2014) · Nature Communications · doi:10.1038/ncomms5222 · Cited by 158
Archetti, M., Ferraro, D. A., & Christofori, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414653112 · Cited by 158
Using a Stem Cell–Based Signature to Guide Therapeutic Selection in Cancer
Shats, I., Gatza, M. L., Chang, J. T., Mori, S., Wang, J., Rich, J. N., & Nevins, J. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1735 · Cited by 147
Hydra and the evolution of stem cells
Bosch, T. C. G. (2009) · BioEssays · doi:10.1002/bies.200800183 · Cited by 145
Targeting the Adaptability of Heterogeneous Aneuploids
Chen, G., Mulla, W. A., Kucharavy, A., Tsai, H.-J., RUBINSTEIN, B. Y., Conkright, J. J., McCroskey, S., Bradford, W. D., Weems, L., Haug, J. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.026 · Cited by 140
Zhu, Z., Khan, M. A., Weiler, M., Blaes, J., Jestaedt, L., Geibert, M., Zou, P., Gronych, J., Bernhardt, O., Korshunov, A., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.04.007 · Cited by 136
Exploiting ecological principles to better understand cancer progression and treatment
Basanta, D., & Anderson, A. R. A. (2013) · Interface Focus · doi:10.1098/rsfs.2013.0020 · Cited by 126
Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation
Ashur‐Fabian, O., Avivi, A., Trakhtenbrot, L., Adamsky, K., Cohen, M., Kajakaro, G., Joel, A., Amariglio, N., Nevo, E., & Rechavi, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404998101 · Cited by 121
A scan for signatures of positive selection in candidate loci for skin pigmentation in humans
Izagirre, N., García, I., Junquera, C., de la Rúa, C., & Alonso, S. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl030 · Cited by 119
Zeron-Medina, J., Wang, X., Repapi, E., Campbell, M. R., Su, D., Castro-Giner, F., Davies, B., Peterse, E. F. P., Sacilotto, N., Walker, G. J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.017 · Cited by 118
Cancer causation: the Darwinian downside of past success?
Greaves, M. F. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00716-7 · Cited by 118
Self-citationp53 ancestry: gazing through an evolutionary lens
Lu, W.-J., Amatruda, J. F., & Abrams, J. M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2732 · Cited by 112
Single-cell mutational profiling and clonal phylogeny in cancer
Potter, N. E., Ermini, L., Papaemmanuil, E., Cazzaniga, G., Vijayaraghavan, G., Titley, I., Ford, A., Campbell, P., Kearney, L., & Greaves, M. (2013) · Genome Research · doi:10.1101/gr.159913.113 · Cited by 107
Self-citationAddressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
Zhao, B., Pritchard, J. R., Lauffenburger, D. A., & Hemann, M. T. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0465 · Cited by 105
Genetic royal cheats in leaf-cutting ant societies
Hughes, W. O. H., & Boomsma, J. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710262105 · Cited by 104
Positive selection in the evolution of cancer
Crespi, B. J., & Summers, K. (2006) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1017/s1464793106007056 · Cited by 102
Humphries, A., Cereser, B., Gay, L. J., Miller, D. S. J., Das, B., Gutteridge, A., Elia, G., Nye, E. L., Jeffery, R. E., Poulsom, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220353110 · Cited by 100
The butterfly effect in cancer: A single base mutation can remodel the cell
Hart, J. R., Zhang, Y., Liao, L., Ueno, L. A., Du, L., Jonkers, M., Yates, J. R., & Vogt, P. K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424012112 · Cited by 89
Cancer stem cells as ‘units of selection’
Greaves, M. F. (2012) · Evolutionary Applications · doi:10.1111/eva.12017 · Cited by 86
Self-citationGenetic and Functional Diversity of Propagating Cells in Glioblastoma
Piccirillo, S. G. M., Colman, S., Potter, N. E., van Delft, F. W., Lillis, S., Carnicer, M.-J., Kearney, L., Watts, C., & Greaves, M. F. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.11.003 · Cited by 84
Self-citationBartesaghi, S., Graziano, V., Galavotti, S., Henriquez, N. V., Betts, J., Saxena, J., Minieri, V., Deli, A., Karlsson, A., Martins, L. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413165112 · Cited by 81
Immunologically silent cancer clone transmission from mother to offspring
Isoda, T., Ford, A. M., Tomizawa, D., van Delft, F. W., de Castro, D. G., Mitsuiki, N., Score, J., Taki, T., Morio, T., Takagi, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904658106 · Cited by 76
Self-citationThe value of monitoring to control evolving populations
Fischer, A., Vázquez-Garćıa, I., & Mustonen, V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409403112 · Cited by 71
NSAIDs Modulate Clonal Evolution in Barrett's Esophagus
Kostadinov, R. L., Kuhner, M. K., Li, X., Sanchez, C. A., Galipeau, P. C., Paulson, T. G., Sather, C. L., Srivastava, A., Odze, R. D., Blount, P. L., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003553 · Cited by 71
Ma, Y. P., Dobbins, S. E., Sherborne, A. L., Chubb, D., Galbiati, M., Cazzaniga, G., Micalizzi, C., Tearle, R. G., Lloyd, A. L., Hain, R. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221099110 · Cited by 57
Self-citationStåhl, P. L., Stranneheim, H., Asplund, A., Berglund, L., Pontén, F., & Lundeberg, J. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.302 · Cited by 55
Addressing the Growing International Challenge of Cancer: A Multinational Perspective
VARMUS, H. E., & Kumar, H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005899 · Cited by 50
Does everyone develop covert cancer?
Greaves, M. F. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3703 · Cited by 33
Self-citationCellular Hyperproliferation and Cancer as Evolutionary Variables
Alvarado, A. S. (2012) · Current Biology · doi:10.1016/j.cub.2012.08.008 · Cited by 31
Are the known chronic diseases related to the human lifespan and its evolution?
Weiss, K. M. (1989) · American Journal of Human Biology · doi:10.1002/ajhb.1310010311 · Cited by 25
Cited by
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065
A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770
Clonal heterogeneity and tumor evolution: past, present, and the future
McGranahan, N., & Swanton, C. (2017) · Cell · doi:10.1016/j.cell.2017.01.018 · Cited by 2,840
“…(Murugaesu et al., 2015), SMO mutations in medulloblastoma (Morrissy et al., 2016), distinct AR amplification events in prostate cancer (Gundem et al., 2015), KMTD2D and CREBBP mutations in follicular lymphoma (Okosun et al., 2014) and PTEN and TP53 mutations, FGFR2 amplifications and…”
Tracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Martinez, A. B., Chan, T. A., Coukos, G., Demaria, S., Deutsch, E., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,119
Metadata
- Authors
- Greaves, M.
- Venue
- Cancer Discovery
- Published
- 2015-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 806-820
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2137549067
- Cited by
- 395
- References
- 188
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.